UK-based pharmaceutical company AstraZeneca has announced that its Tagrisso (osimertinib) has been approved by the Japanese Ministry of Health, Labour and Welfare for the first line treatment of epidermal growth factor receptor (EGFR)-mutated non-small cell […]
A new phase III clinical trial has demonstrated that Pfizer’s tafamidis drug can lower the risk of death in patients suffering from rare heart condition transthyretin amyloid cardiomyopathy. Data revealed a 30% decrease in the […]
Seattle Children’s has opened a chimeric antigen receptor (CAR) T-cell immunotherapy trial for children and young adults with relapsed or refractory non-central nervous system EGFR-expressing solid tumors. In the phase 1 trial, STRIvE-01, cancer-fighting CAR […]
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has outlined how clinical trials regulation will function after the UK leaves the European Union (EU) in March next year. A Brexit implementation period will commence […]
Pfizer has kicked off a late-stage trial assessing efficacy and safety of the investigational gene therapy fidanacogene elaparvovec for the treatment of haemophilia B. The Phase III lead-in study has been initiated following completion of […]